4//SEC Filing
Sendek Joel 4
Accession 0000899243-17-028850
CIK 0001701108other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:06 PM ET
Size
5.6 KB
Accession
0000899243-17-028850
Insider Transaction Report
Form 4
Sendek Joel
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-12-13+27,795→ 27,795 totalExercise: $11.63Exp: 2027-12-12→ Common Stock (27,795 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% on December 13, 2018, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
Spero Therapeutics, Inc.
CIK 0001701108
Entity typeother
Related Parties
1- filerCIK 0001720875
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:06 PM ET
- Size
- 5.6 KB